Login / Signup

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Alexander D MurphyCatharine PorterAnn WhiteAlys IrvingRichard AdamsRuby RayAngela CasbardReem D MahmoodSuman KaranthCong ZhouJulia PughChelsey WheelerVictoria RobertsGiorgio ArnetoliZena SalihJurjees HasanClaire MitchellRobert D MorganAndrew R ClampGordon C Jayson
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
EudraCT 2016-004618-93.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • phase iii
  • physical activity
  • placebo controlled
  • double blind
  • study protocol
  • randomized controlled trial
  • chemotherapy induced